Shares of Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) dropped 7% during mid-day trading on Wednesday . The stock traded as low as $74.32 and last traded at $74.32. Approximately 517 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 6,192 shares. The stock had previously closed at $79.9150.
Wall Street Analysts Forecast Growth
ERFSF has been the topic of several recent analyst reports. Citigroup restated a "neutral" rating on shares of Eurofins Scient in a report on Monday, February 2nd. BNP Paribas Exane upgraded shares of Eurofins Scient to an "outperform" rating in a report on Monday, January 5th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold".
Check Out Our Latest Research Report on Eurofins Scient
Eurofins Scient Stock Down 2.8%
The firm's fifty day moving average is $77.07 and its 200-day moving average is $74.59.
Eurofins Scient Company Profile
(
Get Free Report)
Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.
Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Eurofins Scient, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.
While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
